6505--Radiopharmaceutical Delivery for VASNHCS Single Award IDIQ
ID: 36C26125Q0198Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF261-NETWORK CONTRACT OFFICE 21 (36C261)MATHER, CA, 95655, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/5e95b71136a94f97b62609bb91ea004e/view
Timeline
    Description

    The Department of Veterans Affairs is preparing to solicit proposals for a contract titled "6505--Radiopharmaceutical Delivery for VASNHCS," aimed at providing radiopharmaceuticals to the VA Southern Nevada Healthcare System. This procurement is essential for ensuring the timely delivery of critical medical supplies necessary for patient care and treatment within the healthcare system. The solicitation is expected to be released around February 6, 2025, with quotes due by February 21, 2025, and the contract will be awarded on an unrestricted basis, allowing all responsible sources to participate. Interested contractors can reach out to Contract Specialist Mohammed Hussain at Mohammed.Hussain2@va.gov or by phone at 916-923-4534 for further information.

    Point(s) of Contact
    Mohammed F HussainContract Specialist
    mohammed.hussain2@va.gov
    Files
    Title
    Posted
    36C26125Q0198_1.docx
    The presolicitation notice from the Department of Veterans Affairs outlines an upcoming contract for the delivery of radiopharmaceuticals to the VA Southern Nevada Healthcare System. The notice specifies that the solicitation will be released on or around February 6, 2025, with quotes due by February 21, 2025. It is categorized under the product service code 6505, with the associated NAICS code being 621512, which pertains to pharmaceutical preparation manufacturing. The contract will be awarded as unrestricted, allowing all responsible sources to submit their responses. The contracting officer's contact information is provided, along with a link to the VA’s official website for further details. This document serves as a preliminary announcement to ensure potential contractors are aware of the forthcoming solicitation process and requirements.
    36C26125Q0198.docx
    The document outlines a federal solicitation for an Indefinite Delivery Indefinite Quantity (IDIQ) contract for the provision of radiopharmaceuticals to the VA Southern Nevada Healthcare System (VASNHCS). The contract, effective from April 1, 2025, through March 31, 2030, will allow for multiple ordering periods. The contractor must supply both non-highly enriched uranium (non-HEU) and, if necessary, high-enriched uranium (HEU) medical isotopes for diagnostic and treatment purposes. Key qualifications for bidders include licensing by the US Nuclear Regulatory Commission and adherence to quality control procedures mandated by federal regulations. The contract requires prompt delivery of isotopes, particularly for emergencies requiring delivery within 1.5 to 2.5 hours. Specifications include the need for medical-grade substances, compliant packaging, and effective waste disposal practices. The proposal also emphasizes compliance with stringent security and privacy regulations regarding patient information and the handling of sensitive data. It outlines payment terms, invoicing conditions, and the contractor's obligations related to quality assurance, risk management, and compliance with various oversight bodies. This solicitation highlights the VA's commitment to ensuring continuous, quality service in healthcare provision for veterans while maintaining rigorous standards of safety and compliance.
    36C26125Q0198 LineItems.xlsx
    The document pertains to a Request for Quotation (RFQ) from the VA, focusing on the procurement of various radiopharmaceuticals and medical supplies crucial for imaging and diagnostic procedures, scheduled for the contract period from April 1, 2025, to March 31, 2026. Key items listed include numerous types of radiopharmaceuticals (such as FDG, I-123, and Tc-99m), delivery services for emergency call-outs, and several specific medical kits and cartridges. The RFQ outlines the item descriptions, quantities required, and related costs, showing a detailed financial structure for the procurement process. The document emphasizes the need for responsiveness and the importance of timely deliveries, especially concerning after-hours services. The complexity and diversity of the items required suggest a structured supply chain for radiopharmaceuticals and medical tools vital for the effective operation of healthcare services. This RFQ reflects the government's ongoing commitment to facilitate quality healthcare through procurement that directly supports medical imaging, diagnostics, and treatment procedures, ensuring compliance with healthcare standards and the needs of various medical facilities.
    Similar Opportunities
    6505--PET Radiopharmaceuticals for Nuclear Medicine Department at the Buffalo VA Medical Center
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Positron Emission Tomography (PET) Radiopharmaceuticals for the Nuclear Medicine Department at the Buffalo VA Medical Center. This combined synopsis/solicitation aims to acquire various radiopharmaceuticals, including FDG, Cu64, F18-DCFPyl PSMA, Ga-68 DOTATATE, and F18 Florbetaben, under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract structure with a performance period from April 15, 2025, to April 14, 2028. These radiopharmaceuticals are critical for enhancing healthcare services provided to veterans, ensuring they receive reliable access to essential medical supplies. Interested vendors must submit their quotes by March 28, 2025, at 4:00 PM Eastern Time, and can contact Contracting Officer Jonathan Kilgore at jonathan.kilgore@va.gov or 973-676-1000 for further inquiries.
    6505--Radiopharmaceutical Isotopes (Cardiology)
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of radiopharmaceutical isotopes for the Nuclear Cardiology lab at the William S. Middleton Memorial Veterans Hospital in Madison, Wisconsin. The contract will cover the mixing, dispensing, and delivery of various isotopes, including 99mTc-Tetrofosmin and 67Ga-Gallium Citrate, which are essential for diagnostic testing and quality assurance in cardiac procedures. This initiative underscores the VA's commitment to providing high-quality medical services to veterans while ensuring compliance with federal safety regulations in nuclear medicine practices. Interested vendors must submit their quotations by 5:00 PM on March 20, 2025, to the Contracting Officer, Stacy Massey, at Stacy.Massey@va.gov.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    6525--DEC 2024 Equipment Only Consolidation
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of medical equipment under the solicitation titled "6525--DEC 2024 Equipment Only Consolidation." This initiative aims to acquire advanced imaging equipment, specifically focusing on high-tech medical devices for the National Acquisition Center, with an emphasis on compliance with updated technical specifications and training requirements for clinical staff. The equipment is crucial for enhancing healthcare services provided to veterans, ensuring improved diagnostic capabilities and operational efficiency within VA facilities. Interested vendors must submit their proposals by April 9, 2025, and direct any inquiries to Contract Specialist Hermann A Degbegni at hermann.degbegni@va.gov.
    6525--JAN 2025 Consolidation - HTME with Extended Installation Services (includes Turnkey Services)
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the acquisition of high-tech medical equipment (HTME) along with extended installation services, including turnkey solutions, as part of the JAN 2025 Consolidation initiative. This procurement aims to enhance the capabilities of VA healthcare facilities by providing advanced medical imaging systems and comprehensive support services, ensuring that the equipment meets stringent operational and safety standards. The selected vendors will be responsible for delivering the equipment, conducting site preparations, and providing necessary training for clinical staff, which is crucial for improving patient care and operational efficiency within the VA system. Proposals are due by March 12, 2025, with a projected award date of November 26, 2025. Interested vendors can contact Contracting Officer Michael J Kuchyak at michael.kuchyak@va.gov for further details.
    6505--Aprepitant Capsules
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0029 concerning the procurement of Aprepitant Capsules, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. Offerors are required to provide a unique National Drug Code (NDC) number and ensure that their label is the sole representation on the product, with the contract set for one year plus four optional annual extensions. This procurement is critical for serving veterans and other federal health care facilities, with substantial estimated annual requirements for Aprepitant in various dosages. Interested parties should note that the solicitation will be released around March 25, 2025, with a closing date of April 8, 2025, and are encouraged to contact Matthew Poulin at matthew.poulin@va.gov for inquiries.
    6505--Carvedilol Tablets (VA-25-00048048)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carvedilol Tablets under solicitation number 36E79725R0028, aimed at ensuring a continuous supply for various federal health care entities, including the Department of Defense and the Bureau of Prisons. The contract will be for one year, with the possibility of four additional one-year extensions, requiring offerors to supply drugs labeled with their unique National Drug Code (NDC) without altering existing labels. This procurement is critical for maintaining the availability of essential medications for veterans and affiliated populations, underscoring the VA's commitment to effective health care delivery. Interested bidders should monitor SAM.gov for updates, with the RFP expected to be issued around March 19, 2025, and responses due by April 2, 2025; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov or by phone at 708-202-9027.
    6505--Insulin (VA-25-00026482)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of insulin and its derivatives under the solicitation titled "6505--Insulin (VA-25-00026482)." This procurement aims to establish a reliable supply source for pharmaceutical products, specifically focusing on competitive pricing for a base year plus four option years, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and good manufacturing practices (cGMP). The contract is critical for maintaining quality healthcare for government participants, and interested offerors must submit their proposals by March 14, 2025, at 2:30 PM Central Standard Time, with all submissions including a 0.5% Cost Recovery Fee. For further inquiries, potential contractors can contact Contract Specialist Billy Fong at Billy.Fong@va.gov.
    6505--Hydroxychloroquine SO4 Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a Request for Proposal (RFP) for the procurement of Hydroxychloroquine SO4 Tablets, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will cover an estimated annual requirement of 163,395 bottles of 100-count and 25,853 bottles of 500-count Hydroxychloroquine tablets, with a contract period of one year and four optional one-year extensions. This procurement is critical for maintaining essential medications within veteran and federal healthcare programs. Interested parties should monitor SAM.gov for updates and direct inquiries to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov or (708) 786-4980, with submissions due by March 26, 2025.
    6505--Fludrocortisone Acetate Tablets (VA-25-00047932)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for Fludrocortisone Acetate 0.1MG Tablets, packaged in bottles of 100 tablets, to ensure a reliable supply for various federal entities, including the Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The procurement aims to award a single contract that covers an initial term of one year, with the option for four additional one-year periods, thereby securing an uninterrupted source of this essential medication. The estimated annual requirement for the tablets is 31,127 bottles, and interested suppliers must provide a unique NDC or UPC number along with the product name as it appears on the label. The solicitation is expected to be published on or around March 28, 2025, with proposals due by April 11, 2025; inquiries can be directed to Youlanda Duggar at Youlanda.Duggar@va.gov or by phone at 708-786-4943.